60 Degrees Pharmaceuticals Warrant
SXTPW
7 hedge funds and large institutions have $19.1K invested in 60 Degrees Pharmaceuticals Warrant in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
27.66% more ownership
Funds ownership: 6.29% → 33.96% (+28%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
13% less funds holding
Funds holding: 8 → 7 (-1)
99% less capital inflows, than outflows
Capital inflows: $53 | Capital outflows: $4.67K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$41 |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$12 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$3.16K |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$1.51K |
| 3 |
Clear Street
New York
|
-$4 |
SXTPW Hedge Fund Activity: Q4 2024 in Review
7 of the 7,623 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals Warrant (SXTPW) for Q4 2024, worth a combined $19.1K — down 57% from $43.9K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of SXTPW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.
The largest buyer was Citadel Advisors, adding an estimated $41. The largest seller was Sabby Management, cutting an estimated $3.16K.
- 7 institutional investors held 60 Degrees Pharmaceuticals Warrant (SXTPW) as of Q4 2024, down from 8 in Q3 2024.
- Funds reported $19.1K of 60 Degrees Pharmaceuticals Warrant stock for Q4 2024, down 57% quarter-over-quarter.
- 0 funds opened new 60 Degrees Pharmaceuticals Warrant positions in Q4 2024 and 1 closed out, a net change of -1 holder.
- The largest 60 Degrees Pharmaceuticals Warrant buyer in Q4 2024 was Citadel Advisors, an estimated $41 added.
- The largest 60 Degrees Pharmaceuticals Warrant seller in Q4 2024 was Sabby Management, an estimated $3.16K sold.
Based on aggregated 13F filings for Q4 2024.